News
Blood Donation IRBM Emaroma

IRBM supporting the effort to cope with the impact of coronavirus

There are many ways to face the impact of coronavirus. Due to the worldwide pandemic, there is a blood shortage in several hospitals. The staff at IRBM set up, in partnership with Ema-Roma, a Blood Donation Day. This highly worthwhile initiative has been created so that people can play their part by donating blood on Wednesday May 20th. The donation will provide much needed blood supplies for hospitals and medical centres in the area.
Congrats to our team and all the people involved!

Related Posts

World AIDS Day
World AIDS Day
Today we remember and support #WorldAIDSDay. Medical research has seen amazing advances and milestones over the past few decades. Here at IRBM, we are proud to have played a major role in the discovery of Raltegravir (Isentress) while part of Merck & Co, for the treatment of #HIV-1 infection in combination with other antiretroviral agents.
Antios Therapeutics Announces Agreement With IRBM, INGM And OSR To Acquire Fourth-Generation HBV Capsid Assembly Modulators (CAMs)
Antios Therapeutics Announces Agreement with IRBM, INGM and OSR to Acquire Fourth-Generation HBV Capsid Assembly Modulators (CAMs)
Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV), and IRBM, a drug discovery and early development research institute and global contract research organization, announced today they entered into an agreement for Antios to purchase the IP rights to a novel series of fourth-generation capsid assembly modulators (CAMs) being developed for the treatment of HBV.
Back To Top